Charlotte’s Web Reports Second Quarter 2026 Financial Results
Federal Hemp Framework and Healthcare Strategy Advance; Debenture Conversion Eliminates Largest Liability, Restores Positive Shareholders' Equity; Gross Margin Expands to...
Clinical Trial
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive...
Signant Health Global eCOA Library Surpasses 9,000 Translations, Accelerating Global Study Startup
PHILADELPHIA, Aug. 12, 2026 /PRNewswire/ -- Signant Health, a leading provider of evidence generation solutions for clinical trials, today announced...
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
AFRRI/NIAID Program to Advance Safety and Therapeutic Studies in Rapid Sequence; Top-Line Therapeutic Data Expected in Early FallStudy drug delivered...
Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell(TM) Longevity Clinical Trial
Calgary, Alberta--(Newsfile Corp. - August 12, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
Company reports approximately $20.0 million cash position and extended operating runway following oversubscribed $22.5 million financing, as it advances its...
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World’s First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
The flagship product of the new Xcellara™ cellular wellness platform is backed by a randomized, double-blind, placebo-controlled human clinical trial...
Dr. Oz’s Push to Expand Medicare CBD Access After European Regulators Could Not Establish Safety of Charlotte’s Web Hemp Extract
"Medicare patients should not become the testing ground for cannabinoid products that have not undergone the rigorous FDA drug development...
Zomedica Announces “Fourth Friday at Four” Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across...
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
PH-894 protection for chemical structure, genetic sequencing and broad application for proliferative and infectious diseases in U.S.King of Prussia, Pennsylvania--(Newsfile...
Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies
Hemogenyx Pharmaceuticals Signs Definitive Collaboration Agreement with Cellin Technologies for Manufacturing and Commercialization of HG-CT-1 CAR-T Therapy in EstoniaBinding Agreement...
MMJ Challenges Washington’s “No Product” Cannabinoid Narrative as Dr. Oz Endorses Unvalidated CMS Hemp Products
After eight years, more than $10 million in pharmaceutical development and cannabinoid capsules manufactured by a well known pharmaceutical company,...
NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
SHELTON, CT / ACCESS Newswire / August 10, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue
Acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterpriseAdds an established...
Internationally Recognized Johns Hopkins Oncologist Dr. Stephen J. Noga Joins Immunocine as Chief Medical Officer
Veteran Physician-Scientist and Cellular Therapy Expert to Help Advance the Future of Personalized Cancer Immunotherapy In this video, Dr. Matt...
Reacta Healthcare Announces the Appointment of Iedena Lima as Head of Research and Development
Extensive Pharma and Medtech Sector Experience Strengthens Senior Leadership to Support Growth and Strategic ExpansionDEESIDE, United Kingdom, Aug. 10, 2026...
Something Is Rotten at CMS: Dr. Oz Demands FDA Approval – Then Defends a $500 Medicare Pathway for Unapproved Hemp Products
"Approaching FDA for Formal Approval Is the Right Way to Move Forward" with Cannabinoid Drug Development" stated Dr. Oz. "However...
Cryoport Reports Second Quarter 2026 Financial Results
Second quarter revenue grew 8% year-over-year to $49.0 millionLife Sciences Services revenue increased 15% year-over-yearBioStorage/BioServices revenue grew 25% year-over-year Supporting...
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Strategic milestone advancements for lead clinical candidate PH-762 Initiation of commercial scale API, long term non-clinical toxicology, completion of Phase...
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
SAN DIEGO, CA / ACCESS Newswire / August 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...